McFarland Loren L 4
4 · Inogen Inc · Filed May 15, 2018
Insider Transaction Report
Form 4
Inogen IncINGN
McFarland Loren L
Director
Transactions
- Exercise/Conversion
Common Stock
2018-05-11$16.62/sh+1,000$16,620→ 3,114 total - Sale
Common Stock
2018-05-11$180.57/sh−600$108,344→ 2,514 total - Sale
Common Stock
2018-05-11$181.78/sh−1,525$277,208→ 989 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-11−1,000→ 12,333 totalExercise: $16.62Exp: 2021-03-31→ Common Stock (1,000 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2017.
- [F2]Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $180.18 to $180.85 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 1,525 shares sold in the price range of $181.41 to $182.18 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Subject to the reporting person's continuing service, 1/24th of the total shares subject to the option shall vest every month after April 1, 2014.
- [F5]Previous Form 4 indicated an incorrect expiration date.